MetaADEDB 2.0 @ LMMD
iloperidone
(XMXHEBAFVSFQEX-UHFFFAOYSA-N)
Structure
SMILES
COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C
Type(s)
Approved
ATC code(s)
N05AX14
Molecular Formula:
C24H27FN2O4
Molecular Weight:
426.481
Log P:
4.7645
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
0
TPSA:
64.8
CAS Number(s):
133454-47-4
Synonym(s)
1.
iloperidone
2.
Fanapt
3.
HP 873
4.
HP-873
5.
Zomaril
External Link(s)
MeSHC081732
PubChem Compound71360
BindingDB50034043
ChEBI65173
CHEMBLCHEMBL14376
DrugBankDB04946
DrugCentral3294
IUPHAR/BPS Guide to PHARMACOLOGY87
KEGGdr:D02666
Therapeutic Target DatabaseD0M8VE
ZINC1548097
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1DizzinessFAERS: 52SIDER
US FAERS
2NauseaFAERS: 34SIDER
US FAERS
3VomitingFAERS: 27US FAERS
4TachycardiaFAERS: 25SIDER
US FAERS
5Retrograde ejaculationFAERS: 16SIDER
US FAERS
6HeadacheFAERS: 15US FAERS
7SomnolenceFAERS: 15SIDER
US FAERS
8SyncopeFAERS: 15US FAERS
9PalpitationsFAERS: 13SIDER
US FAERS
10HypotensionFAERS: 12SIDER
US FAERS
11Drug administered to patient of inappropriate ageFAERS: 11US FAERS
12PriapismFAERS: 11US FAERS
13Sexual DysfunctionFAERS: 11US FAERS
14FatigueFAERS: 10SIDER
US FAERS
15Feeling abnormalFAERS: 10SIDER
US FAERS
16AkathisiaFAERS: 9SIDER
US FAERS
17AnxietyFAERS: 9US FAERS
18Chest discomfortFAERS: 9US FAERS
19Drug ineffectiveFAERS: 9US FAERS
20HypersensitivityFAERS: 8US FAERS
21MalaiseFAERS: 8US FAERS
22Tardive DyskinesiaFAERS: 8US FAERS
23Chest PainFAERS: 7US FAERS
24EnuresisFAERS: 7SIDER
US FAERS
25RestlessnessFAERS: 7US FAERS
26TremorFAERS: 7SIDER
US FAERS
27Muscle RigidityFAERS: 6US FAERS
28Completed SuicideFAERS: 5US FAERS
29OverdoseFAERS: 5US FAERS
30AgitationFAERS: 4SIDER
US FAERS
31AstheniaFAERS: 4SIDER
US FAERS
32Blood glucose increasedFAERS: 4US FAERS
33ConstipationFAERS: 4US FAERS
34DystoniaFAERS: 4US FAERS
35HungerFAERS: 4US FAERS
36Incorrect dose administeredFAERS: 4US FAERS
37NervousnessFAERS: 4US FAERS
38Pulmonary EmbolismFAERS: 4US FAERS
39Wrong technique in drug usage processFAERS: 4US FAERS
40Abdominal PainFAERS: 3US FAERS
41AlopeciaFAERS: 3US FAERS
42Cerebrovascular accidentFAERS: 3US FAERS
43DehydrationFAERS: 3SIDER
US FAERS
44DisorientationFAERS: 3US FAERS
45DysarthriaFAERS: 3US FAERS
46DysphoniaFAERS: 3US FAERS
47Erection increasedFAERS: 3US FAERS
48Memory impairmentFAERS: 3US FAERS
49Musculoskeletal stiffnessFAERS: 3SIDER
US FAERS
50Neuroleptic Malignant SyndromeFAERS: 3US FAERS
51Orthostatic hypertensionFAERS: 3US FAERS
52Product administered to patient of inappropriate ageFAERS: 3US FAERS
53SwellingFAERS: 3US FAERS
54Therapeutic response unexpectedFAERS: 3US FAERS
55Urinary IncontinenceFAERS: 3SIDER
US FAERS
56UrticariaFAERS: 3US FAERS
57Wrong technique in product usage processFAERS: 3US FAERS
58AbasiaFAERS: 2US FAERS
59Abdominal discomfortFAERS: 2SIDER
US FAERS
60AmnesiaFAERS: 2SIDER
US FAERS
61AngerFAERS: 2US FAERS
62AnorgasmiaFAERS: 2SIDER
US FAERS
63ApathyFAERS: 2US FAERS
64Back PainFAERS: 2US FAERS
65Bipolar DisorderFAERS: 2US FAERS
66Bipolar I disorderFAERS: 2US FAERS
67Blood prolactin increasedFAERS: 2US FAERS
68CatatoniaFAERS: 2SIDER
US FAERS
69DysgeusiaFAERS: 2US FAERS
70Electrocardiogram abnormalFAERS: 2US FAERS
71Emotional disorderFAERS: 2US FAERS
72EpilepsyFAERS: 2US FAERS
73EpistaxisFAERS: 2SIDER
US FAERS
74Erectile dysfunctionFAERS: 2SIDER
US FAERS
75FibromyalgiaFAERS: 2US FAERS
76IncontinenceFAERS: 2US FAERS
77LethargyFAERS: 2SIDER
US FAERS
78Limb discomfortFAERS: 2US FAERS
79Lip swellingFAERS: 2US FAERS
80Muscle tightnessFAERS: 2US FAERS
81MutismFAERS: 2US FAERS
82Myocardial InfarctionFAERS: 2US FAERS
83Night sweatsFAERS: 2US FAERS
84No adverse eventFAERS: 2US FAERS
85NoduleFAERS: 2US FAERS
86Obsessive-Compulsive DisorderFAERS: 2SIDER
US FAERS
87Oropharyngeal painFAERS: 2US FAERS
88Product label confusionFAERS: 2US FAERS
89Respiratory DepressionFAERS: 2US FAERS
90SomnambulismFAERS: 2US FAERS
91Suicide attemptFAERS: 2US FAERS
92ThirstFAERS: 2SIDER
US FAERS
93Unresponsive to stimuliFAERS: 2US FAERS
94VertigoFAERS: 2SIDER
US FAERS
95Visual ImpairmentFAERS: 2US FAERS
96WheezingFAERS: 2US FAERS
97Accidental overdoseFAERS: 1US FAERS
98AcneFAERS: 1US FAERS
99Activities of daily living impairedFAERS: 1US FAERS
100AmblyopiaFAERS: 1US FAERS
101Anaphylactic shockFAERS: 1US FAERS
102AngioedemaFAERS: 1US FAERS
103Apparent deathFAERS: 1US FAERS
104ArthralgiaFAERS: 1SIDER
US FAERS
105AspermiaFAERS: 1US FAERS
106AtaxiaFAERS: 1US FAERS
107BlepharospasmFAERS: 1US FAERS
108Blood count abnormalFAERS: 1US FAERS
109Blood creatine phosphokinase increasedFAERS: 1US FAERS
110Blood pressure fluctuationFAERS: 1US FAERS
111Blood sodium decreasedFAERS: 1US FAERS
112Blood triglycerides increasedFAERS: 1US FAERS
113BradycardiaFAERS: 1US FAERS
114Breast tendernessFAERS: 1US FAERS
115CandidiasisFAERS: 1US FAERS
116Cardiac ArrestFAERS: 1US FAERS
117Cardiac enzymes increasedFAERS: 1US FAERS
118ChillsFAERS: 1US FAERS
119Creatinine renal clearance decreasedFAERS: 1US FAERS
120Diabetes MellitusFAERS: 1US FAERS
121DiplopiaFAERS: 1US FAERS
122DiscomfortFAERS: 1US FAERS
123Disease ProgressionFAERS: 1US FAERS
124DroolingFAERS: 1US FAERS
125Drug dose omissionFAERS: 1US FAERS
126Drug effect variableFAERS: 1US FAERS
127Drug ineffective for unapproved indicationFAERS: 1US FAERS
128Drug level increasedFAERS: 1US FAERS
129Drug screen positiveFAERS: 1US FAERS
130Dry skinFAERS: 1US FAERS
131DysphemiaFAERS: 1US FAERS
132DysuriaFAERS: 1SIDER
US FAERS
133Ear congestionFAERS: 1US FAERS
134Electrolyte imbalanceFAERS: 1US FAERS
135Essential TremorFAERS: 1US FAERS
136Expired product administeredFAERS: 1US FAERS
137Gastrointestinal PainFAERS: 1US FAERS
138General physical health deteriorationFAERS: 1US FAERS
139Head discomfortFAERS: 1US FAERS
140HyperacusisFAERS: 1US FAERS
141HyperphagiaFAERS: 1US FAERS
142HyperventilationFAERS: 1US FAERS
143Hypoaesthesia facialFAERS: 1US FAERS
144Joint swellingFAERS: 1US FAERS
145Lactation DisorderFAERS: 1US FAERS
146LeukopeniaFAERS: 1SIDER
US FAERS
147Low density lipoprotein increasedFAERS: 1US FAERS
148Medication ErrorFAERS: 1US FAERS
149MenorrhagiaFAERS: 1SIDER
US FAERS
150Mental impairmentFAERS: 1US FAERS
151Mental status changesFAERS: 1US FAERS
152Mouth swellingFAERS: 1US FAERS
153MyalgiaFAERS: 1SIDER
US FAERS
154Myasthenia GravisFAERS: 1US FAERS
155NasopharyngitisFAERS: 1SIDER
US FAERS
156Neck PainFAERS: 1US FAERS
157Neutrophil count decreasedFAERS: 1US FAERS
158Oculogyric crisisFAERS: 1US FAERS
159Orthostatic intoleranceFAERS: 1US FAERS
160Oxygen consumption decreasedFAERS: 1US FAERS
161PallorFAERS: 1US FAERS
162PancytopeniaFAERS: 1US FAERS
163ParanoiaFAERS: 1SIDER
US FAERS
164Peripheral swellingFAERS: 1US FAERS
165PneumoniaFAERS: 1US FAERS
166PolyuriaFAERS: 1US FAERS
167PregnancyFAERS: 1US FAERS
168Product dispensing errorFAERS: 1US FAERS
169Product taste abnormalFAERS: 1US FAERS
170Product use issueFAERS: 1US FAERS
171PruritusFAERS: 1US FAERS
172RhabdomyolysisFAERS: 1US FAERS
173Schizoaffective DisorderFAERS: 1US FAERS
174SchizophreniaFAERS: 1US FAERS
175Skin UlcerFAERS: 1US FAERS
176Skin WrinklingFAERS: 1US FAERS
177Sudden deathFAERS: 1US FAERS
178Supraventricular tachycardiaFAERS: 1US FAERS
179Swelling of eyelidFAERS: 1US FAERS
180Therapy cessationFAERS: 1US FAERS
181ThrombocytopeniaFAERS: 1US FAERS
182TinnitusFAERS: 1SIDER
US FAERS
183Traumatic Brain InjuryFAERS: 1US FAERS
184Unevaluable eventFAERS: 1US FAERS
185Visual brightnessFAERS: 1US FAERS
186White blood cell count decreasedFAERS: 1US FAERS
187heart rateFAERS: 1US FAERS
188nervous system disorderFAERS: 1SIDER
US FAERS
189prostatitisFAERS: 1SIDER
US FAERS
190treatment failureFAERS: 1US FAERS
191Aphthous StomatitisSIDER
192AsthmaSIDER
193BlepharitisSIDER
194BradykinesiaSIDER
195Bulimia NervosaSIDER
196CataractSIDER
197CheilitisSIDER
198CholelithiasisSIDER
199ConjunctivitisSIDER
200DeliriumSIDER
201DermatitisSIDER
202Disturbance in sexual arousalSIDER
203Duodenal UlcerSIDER
204Ear and labyrinth disordersSIDER
205Gastric pH decreasedSIDER
206GastritisSIDER
207HostilitySIDER
208HyperchlorhydriaSIDER
209HypothyroidismSIDER
210InfectionSIDER
211MalnutritionSIDER
212MetrorrhagiaSIDER
213Mood swingsSIDER
214Musculoskeletal discomfortSIDER
215NephrolithiasisSIDER
216NystagmusSIDER
217Restless Legs SyndromeSIDER
218StomatitisSIDER
219TorticollisSIDER
220Urinary RetentionSIDER
221Weight decreasedSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.